'Swallowing razor blades': What to know about the painful symptom linked to latest COVID strain
The World Health Organization recently designated NB.1.8.1 as a variant under monitoring. The strain, nicknamed 'Nimbus,' has reportedly been causing extremely painful sort throats in those who have been infected with it.
Article content
Cases of the Nimbus variant have been rising. It has been detected in 22 countries as of May 18 and made up 10.7 per cent of the global COVID samples taken in late April, WHO said. That was considered a 'significant rise in prevalence' since it only made up 2.5 per cent of global COVID samples four weeks prior. However, WHO deemed the overall risk of Nimbus to be low.
Article content
Article content
'While not specific to COVID-19,' he said, 'this expression has been used to describe sore throat symptoms in some patients with the most recent COVID-19 variant.'
Article content
It has been described by some as 'akin to swallowing shattered glass or razor blades,' news network NTD reported.
Article content
Article content
However, infectious disease specialist at University of California San Francisco Dr. Peter Chin-Hong, told the San Francisco Chronicle that a sore throat from COVID is 'not novel at all.'
Article content
'There has been a range of intensity of sore throat with COVID symptoms all along, including very severe pain,' said Chin-Hong.
Article content
Other symptoms of COVID include runny nose, new or worsening cough, shortness of breath or difficulty breathing, fever, chills, fatigue or weakness, muscle or body aches, new loss of smell or taste, headache, abdominal pain, diarrhea and vomiting.
Article content
Article content
This particular strain 'isn't too different from the Omicron variant, but it does have some tweaks to its spike protein,' according to general practitioner from private healthcare centre Pall Mall Medical in the United Kingdom Dr. Chun Tang, The Independent reported. That means it could 'spread a bit more easily or slip past some of our existing immunity.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Global News
an hour ago
- Global News
Health Minister: Ottawa will try to improve Vaccine Injury Support Program
The federal government will 'try' to improve how the Vaccine Injury Support Program delivers services and financial support to ailing and fragile Canadians, Health Minister Marjorie Michel said Monday. Michel made the brief remarks in New Brunswick, as she publicly answered questions for the first time about the VISP's performance since a five-month Global News investigation was broadcast and published online earlier this month. 'As you know, for now, it's a third party delivering the (VISP) services. We heard that some people are complaining about it. We are tracking this closely with the third party with delivering services. And we will try to improve,' Michel said. 2:41 'Slap in the face': Calls for investigation into Vaccine Injury Support Program Michel was responding to Global News' questions at a news conference she held in Moncton, N.B. She had travelled there to announce the injection of federal money into French-language health services for francophone communities in the Atlantic province. Story continues below advertisement The Liberal government in 2020 announced it would create the VISP to provide financial support to anyone who is seriously and permanently injured by a vaccine as it embarked on the COVID-19 vaccination campaign, the largest such effort in Canadian history. The Public Health Agency of Canada decided to outsource the administration of this program to an Ottawa consulting firm, Oxaro Inc., in 2021. Last week, four Conservative MPs called for a Commons committee investigation into the how VISP is being administered, and a pivotal non-profit health foundation said the effort needs an urgent overhaul because it was too slow. 3:02 Federal Vaccine Injury Support Program leaving some injured people waiting for years Global News' five-month investigation that prompted the outcry revealed that: Get weekly health news Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy Oxaro had received $50.6 million in taxpayer money; $33.7 million has been spent on administrative costs, while injured Canadians received $16.9 million. Updated Health Canada figures released last week show the company has now received $54.1 million and spent $36.3 million on administration costs, with $18.1 million paid to injured Canadians PHAC and Oxaro underestimated the number of injury claims VISP would get, initially predicting 40 per year and then up to 400 valid claims annually. More than 3,317 applications have been filed — of those, more than 1,738 people await decisions on their claims Some injured applicants say they face a revolving door of unreachable VISP case managers and require online fundraising campaigns to survive Some VISP applicants and former staff said Oxaro was unequipped to deliver fully on the program's mission to deliver 'timely and fair' support, and questions emerged about why the Public Health Agency of Canada (PHAC) chose this company over others, while internal documents suggested poor planning from the start When asked at her Moncton news conference whether the Liberal government will renew Oxaro's contract once it expires next year, the Health Minister responded: Story continues below advertisement 'Every option is on the table, for now, I will tell you,' Michel said. 'That's my answer to you, I know everything we heard. It's very, you know, we are tracking it. It's unacceptable what we heard about this. And we are, every option is now on the table.' 'No, people shouldn't wait if they really need services or to get compensation, but as I will tell you it's more complex than this. Sometimes there's reason why they cannot get access to the benefits,' Michel added. Global News obtained internal documents that suggested poor planning from the start as both the government and consulting firm underestimated the number of applications the program would get. In an email to Global News Monday, a VISP spokesman identified only as 'William, Case Escalation Manager,' reiterated earlier comments and responses by the consulting company but confirmed Global News reporting. Story continues below advertisement 'Applications to the program grew to more than 10 times the originally anticipated levels,' William said. 'The program processes, procedures and staffing were adapted to face this unexpected increase in volume.' 'VISP is a program that adapts to changing circumstances and continuously improves to meet its objectives,' William added. 2:48 Whistleblowers allege 'high school' workplace inside federal program 'OXARO and PHAC have been collaborating closely to evaluate how the program can remain agile to handle the workload on hand while respecting budget requirements,' the company said. Oxaro has also said that its monthly invoices to the government include documents and details, which in turn PHAC reviews and approves prior to all payments it gets. –with a file from Anna Mandin, Global News READ MORE OF OUR COVERAGE PART 1: Canada set up a $50M vaccine injury program. Those harmed say it's failing them Story continues below advertisement PART 2: 'Nothing was ready': Inside Canada's Vaccine Injury Support Program PART 3: VISP aimed to curb vaccine injury lawsuits. Now, people are suing in 3 provinces READ OTHER RELATED STORIES: Tory MPs, health group call for investigation and overhaul of vaccine support program Federal auditors target vaccine injury program amid surprise Oxaro office visit 'Breach of trust': Critics slam Ottawa's vaccine injury program 'failure' Is VISP an independent administrator? Here's what some documents say Vaccine injury programs elsewhere also face challenges, criticism Want to contact us about this investigation? Email: or You can also reach Andrew at (416) 550-4684.
Winnipeg Free Press
10 hours ago
- Winnipeg Free Press
FDA names former pharmaceutical company executive to oversee US drug program
WASHINGTON (AP) — The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency's drug program, the latest in a string of leadership changes at the agency. FDA Commissioner Marty Makary announced that Dr. George Tidmarsh, a cancer and pediatric specialist, will direct the agency's Center for Drug Evaluation and Research, which regulates the safety and effectiveness of all U.S. drugs. His appointment comes a month after the center's acting director, Dr. Jacqueline Corrigan-Curay, announced her retirement. As the agency's top drug regulator, Tidmarsh will be charged with following through on a number of commitments made by Makary and his boss, Health Secretary Robert F. Kennedy Jr., including reviewing the safety of the abortion pill mifepristone. The FDA is also scrutinizing certain uses of other long-established drugs, including antidepressants and hormone-replacement drugs for menopause. Tidmarsh founded and led several pharmaceutical companies, including Horizon Pharmaceuticals, maker of an anti-inflammatory medication for arthritis. He has also served as an adjunct professor at Stanford University. The FDA's drug center is the agency's largest unit, with nearly 6,000 staffers responsible for reviewing the safety and effectiveness of new drugs and monitoring the use and marketing of older drugs. About 2,000 FDA staffers have been laid off as part of widescale cuts to the federal health workforce overseen by Kennedy. More than 1,000 others have taken buyouts or early retirement, while many others are reportedly searching for new jobs. The departures have threatened basic FDA operations, including the timely review of new drugs. FDA's drug center hasn't had a permanent director since January, when Dr. Patrizia Cavazzoni stepped down days before President Donald Trump took office. Nearly all of the FDA's senior leadership positions have turned over in recent months, either due to retirements, resignations or actions by administration officials placing them on administrative leave. FDA center directors typically hold their positions for years or even decades, serving across multiple administrations, whether Republican or Democrat. In May, Makary named Dr. Vinay Prasad, a prominent critic of the FDA's COVID response, to run the agency's vaccine center. He was also named to the post of FDA chief medical officer. Prasad joined the agency after his predecessor, longtime vaccine chief Dr. Peter Marks, was forced out in March. The head of FDA's tobacco center was also forced to step down in April. A permanent replacement has not yet been named. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Winnipeg Free Press
17 hours ago
- Winnipeg Free Press
There is no innovation without social accountability
Opinion 'Can a country call itself innovative if its founding wounds remain open?' That's a question I've been sitting with for a while. It came up again during wildfire season, as I watched health systems scramble to meet the needs of evacuated communities, many of them Indigenous, across Northern Manitoba. The co-ordination was messy. Elders were separated from families. People with diabetes or kidney failure were moved hours away from their homes, often without proper followup care. The burnout was visible. And the gaps were predictable. It didn't feel like a health system ready for the future. It felt like one stuck in the past. FILE Modernizing health care involves much more than AI and new technology. Innovation doesn't move forward in isolation. Canada wants to lead in health innovation. We talk about telehealth, AI diagnostics, precision medicine. But how can we claim innovation when access to basic care is still shaped by race, geography, and colonial legacy? Innovation isn't just about shiny tools. It's about what those tools are built on. And who gets to use them. A recent report from Shared Health — REI Data Public Report: Emergency Department Visits & Care, June 2025 — reinforces this reality. Indigenous and Black patients in Winnipeg's ERs wait significantly longer than white patients, despite receiving similar triage scores. According to the report's findings, Indigenous and white patients are assigned comparable urgency levels, a fact that disproves the long-standing myth that Indigenous people 'overuse' emergency services. In fact, Figure 10 of the report clearly shows how closely matched the triage scores are between racial groups, yet Figure 13 reveals that Indigenous and Black patients still face the longest average wait times. Many leave before ever seeing a doctor. This isn't due to differences in the severity of illness. They're triaged the same. It's systemic. It's avoidable. And it's unjust. The data speak volumes: more than half of the patients who leave without being seen are Indigenous. Figure 24 and Figure 27 show that Indigenous people make up nearly two-thirds of all patients who leave against medical advice. These numbers aren't about non-compliance. They reflect broken trust, racial bias, and a system still failing those it was never designed to serve. We can't design our way out of a crisis we're not willing to name. The past isn't behind us. It's stitched into the present. Canada's health systems were not built for Indigenous Peoples; in many cases, they were built against them. From segregated hospitals to forced removals, from medical experimentation to current-day underfunding of on-reserve services. The mistrust isn't imagined. It's earned. And yet, Indigenous communities continue to rise. During COVID-19, many led some of the most co-ordinated, effective pandemic responses in the country. Land-based healing, traditional knowledge, and community governance offer powerful blueprints. But rarely are these seen as the future of health. They're treated as alternatives. Add-ons. Afterthoughts. That's a mistake. Because the future of health care in Canada, especially in a climate-constrained world, requires a different kind of leadership. It requires deep listening, long-term investment, and shared power. It requires systems that are trauma-informed, culturally grounded, and locally governed. It requires the kind of accountability that doesn't just apologize, but reallocates. The wildfires will return. So will floods, smoke and displacement. In just a matter of weeks, Manitoba has faced two separate states of emergency. Climate change is not on the horizon: it's already here. And its impacts won't be felt equally. Indigenous communities are on the frontlines. They've also been leading the responses. But without structural support, they're being asked to do more with less … again. And still, many remain hopeful. That's what humbles me the most. I've spoken with young Indigenous health leaders who are designing mobile clinics rooted in ceremony. Elders who offer counselling and comfort to those evacuated from their territories. Nurses who drive for hours to deliver care where the system doesn't reach. These are not acts of charity. They are acts of sovereignty. The question is whether Canada is willing to follow their lead. To me, equity isn't just a goal. It's a precondition for innovation. If your health system leaves people behind, it's not innovative. Wednesdays A weekly dispatch from the head of the Free Press newsroom. There's a lot of talk these days about reimagining systems. But reimagining requires reckoning. And reckoning means giving up the illusion that progress is linear or automatic. If we want health innovation in Canada, we need social accountability first. We need to invest in relationships, repair harm, and co-create solutions that reflect the wisdom and rights of Indigenous Peoples. Because until Indigenous Peoples are free to define, deliver, and govern their own models of care, on their own lands, then we are not truly advancing. We're just decorating the same old systems. And no amount of technology can cover that up. Marwa Suraj is a naturalized Canadian, a proud Manitoban, and a physician by training. She is Black, Muslim, and a woman: identities that shape her passion for equity, innovation, and social accountability.
